WFC Kronos AI forecast
A 30-trading-day price forecast for Wells Fargo & Company (WFC) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Wells Fargo & Company at $85.34 on 2026-12-08, +3.2% from the last close of $82.66 on 2026-10-27. Eight out of ten sampled paths end between $82.54 and $86.22, and 7 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of WFC
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $82.85 | $81.32 | $85.57 |
| 2026-11-10 | $82.82 | $77.72 | $88.49 |
| 2026-11-17 | $84.09 | $78.39 | $89.24 |
| 2026-11-24 | $84.42 | $77.71 | $88.16 |
| 2026-12-01 | $85.28 | $79.15 | $88.43 |
| 2026-12-08 | $85.34 | $82.54 | $86.22 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for WFC?
- Kronos AI's median forecast for WFC is $85.34 in 30 trading days, +3.2% from the last close, with a 10–90% range of $82.54 to $86.22.
- Is the WFC Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- JPM — JP Morgan Chase & Co.
- BAC — Bank of America Corporation
- C — Citigroup Inc.
- UBS — UBS Group AG Registered
- COF — Capital One Financial Corporation
- MFG — Mizuho Financial Group Inc. Sponosred ADR (Japan)